We have seen inflows into the biotech sector, says Mara Goldstein, Managing Director & Sr. Biotechnology Analyst, Mizuho Americas. They are looking at cash runway and available capital for R&D in the companies. She discusses oncology companies including Arcus (RCUS) with their large amount of cash. She delves into the specifics of several other companies including Xencor (XNCR). Tune in for the specifics.
28 Mar 2022
Trading 360
13 Jan 2023
Market On Close
24 Feb 2023
Morning Trade Live
18 Jan 2023
Trading 360
03 Mar 2023
Market On Close
10 Jan 2023
Morning Trade Live
09 Mar 2023